ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma

Wang, Xueying; Gao, Yuzhang; Miao, Rui; Li, Lisha; Nanding, Abiyasi; Liu, Yong*; Zhang, Xin*华中科技大学; 哈尔滨医科大学; y
American Journal of Cancer Research2023
10阅读
引用收藏
分享

摘要

Head and neck squamous cell carcinoma (HNSCC) are a prevalent malignancy with high mortality and morbidity rates. Therefore, in this study, we aimed to develop a novel risk score model by using a DNA meth-ylation signature associated with ferroptosis to enhance the prognosis prediction of HNSCC. The transcriptome, methylome, and clinical data of HNSCC patients were collected from The Cancer Genome Atlas (TCGA) database. Additionally, data from a methylation dataset in the Gene Expression Omnibus (GEO) database were used for valida-tion. The ferroptosis score (FS) in each patient was calculated using the transcriptome data, and the single-sample gene set enrichment analysis (ssGSEA) was performed to assess ferroptosis activity. Furthermore, a series of bio-chemical experiments including CCK8, colony formation, wound healing, and ROS detection were carried out to evaluate the influence of MTDH on the malignancy of HNSCC. Our results revealed that the FS was associated with patient prognosis, as the patients with high FS had a poor prognosis. The receiver operating characteristic (ROC) curve established based on the ferroptosis-associated DNA methylation signature, demonstrated the excellent pre-dictive power of FS for the 1-, 3-, and 5-year survival of HNSCC. Importantly, this predictive model was successfully validated in the GEO dataset. The nomogram also demonstrated excellent accuracy and reliability, as determined by the calibration curves and the decision curve analysis (DCA) plot. Interestingly, the risk score model was found to be correlated with immune cell infiltration and immunotherapy-related biomarkers, suggesting its potential in predict-ing the immunotherapy response in HNSCC treatment. Moreover, we found that the expression of two risk score model component genes, SETD1B and MTDH, was significantly different between tumor and the adjacent tissues in patients with LSCC, which was also significantly correlated with patient prognosis. Further experimental validation showed that the upregulated expression of MTDH significantly inhibited ferroptosis through regulating GPX4 expres-sion and enhanced the cytotoxicity of ferroptosis inducers in HNSCC cells. In conclusion, we have developed a risk score model by using a ferroptosis-related DNA methylation signature, which can be used as an alternative tool to predict the prognosis of patients with HNSCC. SETD1B and MTDH were identified as the pivotal genes in this model and might play important role in the progression of HNSCC.

学科与关键词

关键词
FerroptosisDNA methylationhead and neck squamous cell carcinoma (HNSCC)prognosispredictive model
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2023
卷期
第 13 卷, 第 11 期
页码
5236-+
语言
ENGLISH
成果收录
SCIE
资助标注
Fundamental Research Funds for the Central Universities of Central South University [2023ZZTS0584]

作者

  • W

    Wang, Xueying (第一作者)

  • G

    Gao, Yuzhang

查看全部 7 位作者收起作者
  • M

    Miao, Rui

  • L

    Li, Lisha

    huazhong univ sci & technol

  • N

    Nanding, Abiyasi

    harbin med univ

  • L

    Liu, Yong (通讯)

  • Z

    Zhang, Xin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417